South Africa’s health regulator authorizes Sinopharm COVID-19 vaccine
Category: #headlines |   By Pankaj Singh |   Date: 2022-02-08

South Africa’s health regulator authorizes Sinopharm COVID-19 vaccine

The South African health regulator has reportedly approved Sinopharm, a COVID-19 vaccination from China. A senior health executive claimed that the government doesn’t plan to acquire vaccine doses for now.

South Africa, which has been hit the hardest by the COVID-19 pandemic in terms of infections and deaths, has deployed the Pfizer-BioNTech and Johnson & Johnson (J&J) vaccines in its vaccination campaign after negotiating supply agreements with the two American pharmaceutical corporations.

However, due to an overstock of vaccines, the government postponed certain vaccination distribution programs scheduled late last year, as uncertainty slowed the uptake.

According to SAHPRA, the vaccine was approved on the basis of accepted safety, quality, and efficacy evidence given by MC Pharma, which is a local regulatory pharmaceutical business that has collaborated with Sinopharm.

The vaccine has been approved for those aged 18 and above, subject to certain restrictions, including that it has to be given in accordance with the national vaccination schedule and that periodic safety updates are provided.

Nicholas Crisp, Deputy Director-General of the health department stated that they would not be purchasing the vaccines as of now, since plenty of stock is available in stores.

For those unaware, the World Health Organization (WHO) approved a Sinopharm COVID-19 vaccine for emergency use in May. Clinical trials revealed that it was less effective against symptomatic disease than the Pfizer-developed injection.

In December, the WHO urged that persons who had received an inactivated COVID-19 vaccination, made by Sinopharm, Sinovac Biotech, and Bharat Biotech in India, have a booster dose to counter fading immunity.

Inactivated vaccinations work by using chemicals, heat, or radiation to inactivate or destroy the SARS-CoV-2 virus. It is worth mentioning here that around 42% of South Africa's adult population which is around 40 million people has been fully vaccinated so far.

 

Source Credit:

https://www.msn.com/en-us/news/other/south-african-regulator-approves-sinopharm-covid-vaccine/ar-AATy3nm?ocid=bingcovid

  • shareShare
  • Twitter
  • Facebook
  • LinkedIn


About Author

Pankaj Singh     Twitter

Pankaj Singh

With a commendable experience of content creation under his belt, Pankaj Singh, a qualified Post Graduate in Management, boasts of having worked as a freelance writer and an insurance underwriter. Additionally, Pankaj has also enriched his qualification portfolio with Read more...

More News By Pankaj Singh

Oracle Prepared to Assist Canadian Banks with Open Banking Transition

Oracle Prepared to Assist Canadian Banks with Open Banking Transition

By Pankaj Singh

The American tech giant Oracle has reportedly expressed its readiness to assist Canadian banks with their open banking requirements, offering necessary tools as needed once the country decides to make this service available. Sonny Singh, the Execu...

Goldman Sachs explores sale options for its fintech unit GreenSky

Goldman Sachs explores sale options for its fintech unit GreenSky

By Pankaj Singh

GreenSky was bought by Goldman Sachs in 2021 for USD 2.24 billion stock deal. Goldman Sachs quotes GreenSky as ‘good business’. Goldman cites itself not best suited to lead the fintech in long run . In the recent turn of event...

Tesla ordered to pay ex-employee over $3.2 Mn in damages over racism case

Tesla ordered to pay ex-employee over $3.2 Mn in damages over racism case

By Pankaj Singh

Electric car manufacturer, Tesla, has reportedly been ordered by a federal jury to pay more than USD 3.2 million in damages to a former worker, following his win in a racial harassment suit. Owen Diaz, who worked as a lift operator at the firm’...